By Momo Yamamoto, Senior Investor Research Analyst, LSN
One of the most valuable aspects of attending RESI Boston is the opportunity to hear directly from the investors and strategic partners actively funding and partnering with early-stage life science companies.
This year’s agenda features an outstanding lineup of leaders representing global pharmaceutical companies, venture capital firms, strategic investors, government funding organizations, and mission-driven investment groups. Their sessions will provide firsthand insights into today’s investment landscape, what they look for in emerging technologies, and how startups can position themselves for successful fundraising and partnership discussions.
 Farnaz Bakhshi American Cancer Society BrightEdge |
 Alan Chiu Breakthrough T1D |
 Yvanka de Soysa Foreground Capital |
 Shane Duffy Avanos Medical |
 Nimisha Gupta Jazz Pharmaceuticals |
 Sam Gussman-Toh ARPA-H |
 Jonathan Illicki Industrifonden |
 Nikhil Mutyal AstraZeneca |
 Rohit Nuwal TELUS Ventures |
 Parthiban Rajasekaran Sanofi |
 Armin Rump Otsuka Pharmaceutical Co., Ltd |
Register Today for RESI Boston 2026
Don’t miss your opportunity to learn directly from these industry leaders while connecting with hundreds of active investors, strategic partners, and innovative life science companies during Biotech Week Boston.
Join us September 22–23 in Boston, followed by three days of virtual partnering on September 25, 28, and 29.
Register now to secure your spot, take advantage of Early Bird savings, and begin scheduling meetings with the global life science investment community.
| Register for RESI Boston 2026 |
Next Phase Newsletter 